PIK3CA and diffuse large B-cell lymphoma: The presence of several PIK3CA oncogenic mutations has been reported in DLBCL patients [55], as well as PIK3CA has been investigated for its clinicopathological significance; however, no data have been reported in indolent B-NHLs.